Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,692 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.
Wang J, Cheng P, Pavlyukov MS, Yu H, Zhang Z, Kim SH, Minata M, Mohyeldin A, Xie W, Chen D, Goidts V, Frett B, Hu W, Li H, Shin YJ, Lee Y, Nam DH, Kornblum HI, Wang M, Nakano I. Wang J, et al. Among authors: xie w. J Clin Invest. 2020 Nov 2;130(11):6187. doi: 10.1172/JCI144618. J Clin Invest. 2020. PMID: 33044225 Free PMC article. No abstract available.
Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.
Wang J, Cheng P, Pavlyukov MS, Yu H, Zhang Z, Kim SH, Minata M, Mohyeldin A, Xie W, Chen D, Goidts V, Frett B, Hu W, Li H, Shin YJ, Lee Y, Nam DH, Kornblum HI, Wang M, Nakano I. Wang J, et al. Among authors: xie w. J Clin Invest. 2017 Aug 1;127(8):3075-3089. doi: 10.1172/JCI89092. Epub 2017 Jul 24. J Clin Invest. 2017. Retraction in: J Clin Invest. 2020 Nov 2;130(11):6187. doi: 10.1172/JCI144618 PMID: 28737508 Free PMC article. Retracted.
Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.
Wang J, Cheng P, Pavlyukov MS, Yu H, Zhang Z, Kim SH, Minata M, Mohyeldin A, Xie W, Chen D, Goidts V, Frett B, Hu W, Li H, Shin YJ, Lee Y, Nam DH, Kornblum HI, Wang M, Nakano I. Wang J, et al. Among authors: xie w. J Clin Invest. 2020 Sep 1;130(9):5027. doi: 10.1172/JCI142404. J Clin Invest. 2020. PMID: 32870163 Free PMC article. No abstract available.
NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway.
Xiang J, Alafate W, Wu W, Wang Y, Li X, Xie W, Bai X, Li R, Wang M, Wang J. Xiang J, et al. Among authors: xie w. Cell Death Dis. 2022 Jan 14;13(1):58. doi: 10.1038/s41419-022-04512-6. Cell Death Dis. 2022. PMID: 35031599 Free PMC article.
9,692 results